A double-blind, parallel, multicenter comparison ofL-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys-Reference-Cited by-同舟云学术

A double-blind, parallel, multicenter comparison ofL-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys

Published:2008 Issue:7 Volume:146A Page:803-812
ISSN:1552-4825
Container-title:American Journal of Medical Genetics Part A
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Torrioli M. Giulia,Vernacotola Silvia,Peruzzi Laura,Tabolacci Elisabetta,Mila Montserrat,Militerni Roberto,Musumeci Sebastiano,Ramos Feliciano J.,Frontera Marìa,Sorge Giovanni,Marzullo Elisabetta,Romeo Giusi,Vallee Louis,Veneselli Edvige,Cocchi Elena,Garbarino Eleonora,Moscato Umberto,Chiurazzi Pietro,D'Iddio Stefania,Calvani Menotti,Neri Giovanni

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Reference42 articles.

1. Fenfluramine and Methylphenidate in Children with Mental Retardation and ADHD: Clinical and Side Effects

2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association.

3. Carnitine--metabolism and functions

4. In Vitro Reactivation of the FMR1 Gene Involved in Fragile X Syndrome

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients;Molecular Biology Reports;2024-04-05

2. Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence;Expert Opinion on Pharmacotherapy;2024-02-11

3. Integrative and Complementary Medicine in Psychiatry;Tasman’s Psychiatry;2024

4. Epigenetic causes of intellectual disability—the fragile X syndrome paradigm;Neuropsychiatric Disorders and Epigenetics;2024

5. Measuring Effectiveness of Treatments in Rare Disorders, Evidence from Clinical Trials in Fragile X Syndrome;2023-10-23